SCHEMBL30984034

SCHEMBL30984034

CCOC(=O)COc1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2ccccc2)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.37
▸ METAP1 P53582 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ POLB P06746 1/20 0.36
▸ P2RX3 P56373 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ HPGD P15428 3/20 0.35
▸ CNR1 P21554 3/20 0.35
▸ CNR2 P34972 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983954 0.92 PLA2G2A (0.39) PIK3CDKMT2AADORA2BCNR1CNR2
SCHEMBL30983502 0.91 NPC1 (0.38) PIK3CDKMT2APOLBHPGDCNR1
SCHEMBL30983924 0.91 PLA2G2A (0.38) PIK3CDKMT2ACNR1CNR2
SCHEMBL30983512 0.89 KMT2A (0.36) PIK3CDKMT2APOLBCNR1CNR2
SCHEMBL30983880 0.88 MAOB (0.36) PIK3CDKMT2APOLBHPGDCNR1
SCHEMBL30983976 0.88 MAOB (0.36) PIK3CDKMT2APOLBHPGDCNR1
SCHEMBL31321937 0.88 PLA2G2A (0.40) PIK3CD
SCHEMBL30983449 0.87 ALDH1A1 (0.42) PIK3CDKMT2AADORA2BALDH1A1KDM4E
SCHEMBL30983424 0.87 HTR1D (0.43) KMT2APOLBHPGDCNR1ALDH1A1
SCHEMBL30983817 0.86 CNR1 (0.41) PIK3CDKMT2APOLBHPGDCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback